Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment With Synthetic Adrenocorticotropic Hormone (ACTH) in Patients With Membranous Nephropathy and High Risk for Renal Failure (ACTHiMeN)
This study is currently recruiting participants.
Study NCT00694863   Information provided by Radboud University
First Received: June 9, 2008   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Idiopathic Membranous Nephropathy
Additional conditions recognized in this trial
Glomerulonephritis, Membranous
Kidney Diseases
Kidney Failure
More general conditions related to this trial
Autoimmune Diseases
Glomerulonephritis
Immune System Diseases
Nephritis
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
tetracosactide hexacetaat
Additional drug interventions recognized in this trial
Adrenocorticotropic Hormone
Adrenocorticotropin zinc
Cosyntropin
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Radboud University
Dutch Kidney Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services